AGT and acute kidney injury: A small subgroup analysis of patients treated with RRT showed that patients receiving angiotensin II required less RRT than placebo and were more likely to survive to day 28 (53% versus 30%; P=0.012), the results need to be validated in a larger SA-AKI cohort (51).